Back to Search
Start Over
Improving 10-year atherosclerotic cardiovascular disease estimation management using a Smartphrase for automated risk screening.
- Source :
-
Journal of the American Association of Nurse Practitioners [J Am Assoc Nurse Pract] 2022 Oct 01; Vol. 34 (10), pp. 1151-1155. Date of Electronic Publication: 2022 Oct 01. - Publication Year :
- 2022
-
Abstract
- Background: Cardiovascular disease (CVD) is the most common cause of death in the United States, and 90% of cardiovascular events are preventable. The 2020 American College of Cardiology/American Heart Association Guidelines on the Primary Prevention of Cardiovascular Disease recommends 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimates for 40- to 75-year-old adults with CVD risk indications to decrease the likelihood of cardiovascular events.<br />Local Problem: At the project site, the 10-year ASCVD risk estimates were rarely completed by providers. The purpose of this project was to increase 10-year ASCVD risk estimation screening and improve pharmacological therapy for 40- to 75-year-old patients with CVD risk indications.<br />Methods: To increase 10-year ASCVD risk estimation screening and improve pharmacological therapy, a multifaceted bundle was created for providers.<br />Interventions: Three interventions were initiated: an electronic health record Smartphrase was created to produce automatic 10-year risk scores; laminated paper reminders for the Smartphrase were visible on providers' desks; educational in-services were performed to promote risk score adherence.<br />Results: The project aims were achieved with an increase from a 14% completion rate for 10-year ASCVD risk estimation during the preintervention phase to a 98% completion rate at the end of the postintervention phase. Appropriate pharmacological therapy improved from a 64% rate during the preintervention phase to a maximum rate of 79% during postintervention.<br />Conclusion: The project was effective at increasing risk estimate completion and improving appropriate pharmacological therapy. There was an increase in provider-patient discussions toward primary prevention for cardiovascular events.<br />Competing Interests: Competing interests : The author reports no conflicts of interest.<br /> (Copyright © 2022 American Association of Nurse Practitioners.)
Details
- Language :
- English
- ISSN :
- 2327-6924
- Volume :
- 34
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Journal of the American Association of Nurse Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 35834421
- Full Text :
- https://doi.org/10.1097/JXX.0000000000000757